** CREDENTIALED MEDIA ONLY **
WHAT:
A media briefing to discuss approval of a medically needed pain medicine
(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)
Advertisement
WHO:
-- Douglas Throckmorton, M.D., deputy director, Center for Drug Evaluation and Research (CDER), FDA
Technical Experts:
--Sharon Hertz, M.D., deputy director, Division of Anesthesia, Analgesics, and Rheumatoid Products, CDER, FDA
Advertisement
--Michael Levy, director, Division of New Drugs and Labeling Compliance, Office of Compliance, CDER, FDA
WHEN:
Tuesday, Jan. 26, 2010 at 11:30 a.m. EST
HOW:
Reporters can participate by calling 800-369-1169. International callers will need to dial 517-308-9400. The passcode is "FDA."
A replay of the briefing will be available one hour after the event ends until Feb. 2, 2010 at 11:59 p.m. EST. To hear the replay, callers in the United States and Canada can dial 866-501-8767. International callers can dial 203-369-1847.
CONTACT: Christopher Kelly of FDA, +1-301-796-4676; [email protected]
/PRNewswire-USNewswire -- Jan. 26/
SOURCE U.S. Food and Drug Administration
